Skip to main content

Table 1 Cohort description

From: In vitro cell culture of patient derived malignant pleural and peritoneal effusions for personalised drug screening

CaseLocationAgeSexTumour typeDiagnostic markersVolume (ml)Cell count (M/ml)Drug test
1Pleura60MaleGIT-CaCDX2+452.3No
2Pleura56MaleMelanomaMelan-A+26002.5No
3Pleura71FemaleGIT-CaCDX2+20004.2No
4Ascites67MaleGIT-CaCDX2+18000.6No
5Ascites46FemaleBreast-CaER+6006No
6Ascites68FemaleMelanomaMelan-A−, S100+20001.4No
7Pleura43MaleGIT-CaCDX2+12000.38No
8Pleura92MaleLADCTTF-1+8000.38No
9Pleura54FemaleLADCTTF-1+16000.03Yes
10Ascites68FemaleOvarian-CaER+25000.08Yes
11Pleura43FemaleOvarian-CaER+11000.12Yes
12Pleura72MaleLADCTTF1−15000.5Yes
13Pleura65FemaleBreast-CaER+20000.4Yes
  1. TTF-1 thyroid transcription factor 1, ER estrogen receptor, LADC lung adenocarcinoma, Breast-Ca breast carcinoma, Ovarian-Ca ovarian carcinoma, GIT-Ca gastrointestinal carcinoma, + positive, − negative